Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.83 USD | -1.08% |
|
+12.96% | -87.57% |
24/06 | Amylyx Pharmaceuticals, Inc.(NasdaqGS:AMLX) dropped from S&P Pharmaceuticals Select Industry Index | CI |
21/06 | Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-87.57% | 12Cr | |
+2.97% | 9.47TCr | |
-4.08% | 3.73TCr | |
-13.26% | 3.27TCr | |
+74.33% | 2.77TCr | |
-11.58% | 1.62TCr | |
-1.66% | 1.39TCr | |
-11.67% | 1.16TCr | |
+190.36% | 1.09TCr | |
-52.61% | 954.09Cr |
- Stock Market
- Equities
- AMLX Stock
- News Amylyx Pharmaceuticals, Inc.
- Baird Downgrades Amylyx Pharmaceuticals to Neutral From Outperform, Cuts Price Target to $4 From $37